|
|
|
||||
| Home Help Feedback Subscriptions Archive Search | |||||
The fully linked HTML version of this article has now been published.
Persistent activation of the transcription factor STAT3 has been detected in many types of cancer and plays an important role in tumor progression, immune evasion and metastasis. To analyze persistent STAT3 activation we coexpressed STAT3 with v-Src. We found that tyrosine phosphorylation of STAT3 by v-Src is independent of Janus kinases (Jaks), the canonical activators of STATs. The STAT3-induced feedback inhibitor, suppressor of cytokine signaling 3 (SOCS3), did not interfere with STAT3 activation by v-Src. However, the protein inhibitor of activated STAT3 (PIAS3) suppressed gene induction by persistently activated STAT3. We measured nucleocytoplasmic shuttling of STAT3 in single cells by bleaching the YFP moiety of double-labelled STAT3-CFP-YFP in the cytoplasm. Analysis of the subcellular distribution of CFP and YFP fluorescence over time by mathematical modeling and computational parameter estimation revealed that activated STAT3 shuttles more rapidly than non-activated STAT3. Inhibition of exportin-1-mediated nuclear export slowed down nucleocytoplasmic shuttling of v-Src-activated STAT3 resulting in reduced tyrosine phosphorylation, decreased induction of STAT3 target genes and increased apoptosis. We propose passage of persistently activated STAT3 through the nuclear pore complex as a new target for intervention in cancer.
This article has been cited by other articles:
JCS ePress
online publication date 28 Aug 2007
doi: 10.1242/jcs.03482
This Article ![]()
![]()
Full Text (PDF)
![]()
All Versions of this Article:
jcs.03482v1
120/18/3249
most recent![]()
Alert me when this article is cited
![]()
Alert me if a correction is posted
![]()
Services ![]()
![]()
Email this article to a friend
![]()
Similar articles in this journal
![]()
Similar articles in PubMed
![]()
Alert me to new issues of the journal
![]()
Download to citation manager
![]()
![]()
Citing Articles ![]()
![]()
Citing Articles via HighWire
![]()
Citing Articles via Google Scholar
![]()
Google Scholar ![]()
![]()
Articles by Herrmann, A. ![]()
Articles by Müller-Newen, G. ![]()
Search for Related Content
![]()
PubMed ![]()
![]()
PubMed Citation
![]()
Articles by Herrmann, A.
![]()
Articles by Müller-Newen, G.
![]()
Social Bookmarking ![]()
![]()
What's this?
Research Article
Nucleocytoplasmic shuttling of persistently activated STAT3
* Author for correspondence (e-mail: mueller-newen{at}rwth-aachen.de)
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
![]()
![]()

![]()
![]()
![]()
M. Benekli, H. Baumann, and M. Wetzler
Targeting Signal Transducer and Activator of Transcription Signaling Pathway in Leukemias
J. Clin. Oncol.,
September 10, 2009;
27(26):
4422 - 4432.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
W. B. Grant
Vitamin D May Reduce Prostate Cancer Metastasis by Several Mechanisms Including Blocking Stat3
Am. J. Pathol.,
November 1, 2008;
173(5):
1589 - 1590.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
E. C. Brantley, L. B. Nabors, G. Y. Gillespie, Y.-H. Choi, C. A. Palmer, K. Harrison, K. Roarty, and E. N. Benveniste
Loss of Protein Inhibitors of Activated STAT-3 Expression in Glioblastoma Multiforme Tumors: Implications for STAT-3 Activation and Gene Expression
Clin. Cancer Res.,
August 1, 2008;
14(15):
4694 - 4704.
[Abstract]
[Full Text]
[PDF]
![]()
© The Company of Biologists Ltd 2007